Marsha Pharma

What Marsha Pharma does

Marsha Pharma Private Limited is an Indian pharmaceutical manufacturer founded in 1997 and headquartered in Vadodara, Gujarat, with a corporate office in Kolkata. The company operates a 22,000 sq. ft. manufacturing facility in Tal Savli, Vadodara, certified under India's revised Schedule M standards, with production capabilities spanning tablets, capsules, liquids, ointments, eye drops, syrups, and injections. Marsha markets an in-house portfolio of approximately 60 branded generic formulations organized into six therapeutic categories: general medicine and health products, cardiovascular care, neurological and psychotropic products, skin and eye care, antibiotics, and veterinary products.

The business operates two parallel revenue streams. The primary stream is ethical marketing of own-branded generics through a 250-person dedicated domestic sales force covering the Indian market; the secondary stream is contract manufacturing services for a select set of pharmaceutical customers. The company also states that it markets and distributes products in international markets alongside domestic operations, though international revenue contribution is not disclosed. Quality control, R&D, and manufacturing occur at the single Vadodara site, with no external institutional capital, M&A activity, or disclosed partnerships in the source data.

Ownership is family/founder-led, with the management team comprising Sabyasachi Sinharoy as Managing Director, Prasun Roy as Director and CEO, Meena Chatterjee, and Brinda Roy. The company does not publicly disclose pricing, revenue, or customer accounts, and engagement for both branded and contract manufacturing inquiries is handled through direct phone and email contact. The overall operating posture is that of a stable, mid-sized Indian formulation manufacturer focused on affordable branded generics and B2B contract manufacturing rather than innovation-driven or specialty pharmaceutical positioning.

Name

Marsha Pharma

Legal name

Marsha Pharma Private Limited

Website

https://marshapharma.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industry

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

Keywords

• Pharmaceutical manufacturing
• Branded generics
• Contract manufacturing
• Pharmaceutical formulations
• Veterinary pharmaceuticals

Headquarters

HQ city

Vadodara

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Ethical Marketing of Own Brands: Manufacturing and ethical marketing of pharmaceutical products under company brands including branded generics, OTC products, and specialty medicines covering capsules, tablets, ointments, creams and liquids.
2. Contract Manufacturing: Contract manufacturing services for select pharmaceutical customers, providing high quality manufacturing and delivery services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Marsha Pharma Private Limited manufactures branded generic pharmaceutical formulations across tablets, capsules, liquids, and ointments at its Revised Schedule M-certified facility in Vadodara, Gujarat. The company ethically markets these branded generics through its own 250-person domestic sales force and provides contract manufacturing services to select pharmaceutical customers. Its portfolio spans six therapeutic categories including general medicine, cardiovascular care, neurological/psychotropic, skin and eye care, antibiotics, and veterinary products.

Product overview

Marsha Pharma Private Limited is a pharmaceutical manufacturing company based in Gujarat, India, engaged in ethical marketing of its own branded generic pharmaceutical products and contract manufacturing services. The company operates a state-of-the-art manufacturing facility spanning 22,000 square feet in Tal Savli, District Vadodara, certified under revised Schedule M, with capabilities across tablets, capsules, liquids, and ointments. The product portfolio is organized into six therapeutic categories: General Medicine & Health Products (analgesics, vitamins, supplements, cough syrups, mouthwash), Cardiovascular Care Products (antihypertensives, statins, beta-blockers), Neurological and Psychotropic Products (antidepressants, anxiolytics, nootropics, anticonvulsants), Skin and Eye Care Products (antifungals, ointments, eye drops, antihistamines), Antibiotic Products (penicillins, fluoroquinolones, macrolides), and Veterinary Products (anthelmintics, nutritional supplements, herbal formulations). The company markets over 60 branded generic formulations across these categories, supported by a 250-person sales force for domestic Indian market distribution.

Differentiator

Problem solved

Functional benefit

Products and services

• General Medicine & Health Products

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Cipla: One of India's largest pharmaceutical companies with an extensive branded-generic portfolio across respiratory, cardiovascular, and many other categories. Overlaps significantly with Marsha's therapeutic coverage but at much larger scale and global footprint.

Direct peers

• Ajanta Pharma: India-based pharmaceutical company with branded generics in dermatology, ophthalmology, cardiology, and pain management. Comparable therapeutic categories (especially skin and eye care, cardiovascular) and India+internationals operating model.
• Unichem Laboratories: India-based pharmaceutical company with domestic manufacturing of branded generics in cardiovascular, CNS, and anti-infective categories. Comparable in therapeutic focus and mid-sized Indian pharma profile.
• Ipca Laboratories: Indian pharmaceutical company with significant domestic branded generics business and contract manufacturing/API capabilities. Comparable in mixed own-brand and B2B manufacturing focus across multiple dosage forms.
• Torrent Pharmaceuticals: Mid-to-large Indian pharmaceutical company with strong presence in cardiovascular, CNS, and gastroenterology therapeutic categories. Comparable in operating geographies (India plus international) and branded-generic model.
• Alkem Laboratories: Indian branded-generic pharmaceutical company with a broad portfolio across many of the same therapeutic categories (anti-infectives, cardiovascular, CNS, dermatology) and a strong domestic sales force. Closely comparable in product mix and Indian market focus.
• Alembic Pharmaceuticals: Indian pharmaceutical manufacturer with branded generics and API manufacturing across multiple therapeutic areas including cardiovascular, antibiotics, and dermatology. Comparable in therapeutic breadth and India-centric operations.
• Mankind Pharma: India-focused branded generic pharmaceutical company with a large domestic sales force and broad therapeutic coverage. Highly comparable business model to Marsha in ethical marketing of affordable generics across multiple therapeutic categories.
• Lincoln Pharmaceuticals: Ahmedabad-based Indian pharmaceutical manufacturer with branded generics across multiple therapeutic areas including dermatology, gynecology, and antibiotics. Comparable mid-sized Indian pharma with similar domestic and export mix.

Regional players

• Panacea Biotec: Indian pharmaceutical and biotech company with branded generics and vaccine manufacturing. Comparable in therapeutic breadth and Indian market focus, though with stronger biotechnology orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/marshapharma
• LinkedInlinkedin.com/company/marsha-pharma-private-limited

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Marsha Pharma